| RS11568437 |
SLC7A7
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysinuric protein intolerance, Autoinflammatory syndrome |
| RS1156844272 |
DOLK
|
Health Risk |
Conflicting classifications of pathogenicity |
DK1-congenital disorder of glycosylation, Cardiovascular phenotype |
| RS115684579 |
HSD17B3
|
Health Risk |
Conflicting classifications of pathogenicity |
Testosterone 17-beta-dehydrogenase deficiency, Testosterone 17-beta-dehydrogenase deficiency |
| RS11568513 |
SLC22A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal carnitine transport defect, SLC22A5-related disorder |
| RS11568514 |
SLC22A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal carnitine transport defect, See cases |
| RS11568520 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS11568530 |
SLC17A8
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 25, Autosomal dominant nonsyndromic hearing loss 25 |
| RS1156864297 |
MFSD8
|
Health Risk |
Likely pathogenic |
Macular dystrophy with central cone involvement, Macular dystrophy with central cone involvement |
| RS115686643 |
LARGE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy type B6, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS1156871090 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS115687408 |
PDSS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-encephaloneuropathy-obesity-valvulopathy syndrome, Deafness-encephaloneuropathy-obesity-valvulopathy syndrome |
| RS1156880851 |
MOCS1
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS1156891581 |
RPGR
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked cone-rod dystrophy 1, Primary ciliary dyskinesia |
| RS1156894268 |
IRF7
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 39, Immunodeficiency 39 |
| RS1156900338 |
IKBKG
|
Health Risk |
Pathogenic |
— |
| RS1156904586 |
ATP8A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Cerebellar ataxia |
| RS1156913215 |
BBS10;OSBPL8
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 10, Bardet-Biedl syndrome |
| RS1156940293 |
TERT
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 2 |
| RS1156948793 |
WNT10A
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS11569534 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9 |
| RS11569541 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
C3 glomerulonephritis, Atypical hemolytic-uremic syndrome |
| RS1156965453 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, Inborn genetic diseases |
| RS1156976510 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1156977888 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1156984408 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1156986606 |
STAT5B
|
Health Risk |
Pathogenic |
Growth hormone insensitivity with immune dysregulation 1, autosomal recessive |
| RS115698674 |
SH2B1
|
Health Risk |
Conflicting classifications of pathogenicity |
SH2B1-related disorder, SH2B1-related disorder |
| RS1156987118 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS115698972 |
IKBKB
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to IKK2 deficiency, IKBKB-related disorder |
| RS11570045 |
MYBPC3
|
Health Risk |
Likely pathogenic |
— |
| RS11570060 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Left ventricular noncompaction 10 |
| RS11570077 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy |
| RS11570079 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS11570112 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS115701916 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS11570255 |
EDN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hirschsprung disease, susceptibility to |
| RS1157030138 |
FBXO7
|
Health Risk |
Pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS1157052586 |
VPS13C
|
Health Risk |
Likely pathogenic |
Autosomal recessive early-onset Parkinson disease 23, Autosomal recessive early-onset Parkinson disease 23 |
| RS1157058742 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1157060069 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS11570607 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
PLA2G6-associated neurodegeneration, Spastic ataxia |
| RS1157065841 |
NEK1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS1157079200 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1157097082 |
SNAP29
|
Health Risk |
Likely pathogenic |
— |
| RS1157097825 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial septal defect 5, Hypertrophic cardiomyopathy 11 |
| RS115710123 |
SEC63
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant medullary cystic kidney disease with or without hyperuricemia, SEC63-related disorder |
| RS1157108621 |
CDH3
|
Health Risk |
Pathogenic |
Retinal dystrophy, Congenital hypotrichosis with juvenile macular dystrophy |
| RS11571098 |
REN
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesis |
| RS1157132860 |
SMO
|
Health Risk |
Pathogenic |
Congenital hypothalamic hamartoma syndrome, Congenital hypothalamic hamartoma syndrome |
| RS1157135425 |
TCN2
|
Health Risk |
Pathogenic |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS11571509 |
TGIF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Disorder of sexual differentiation, Disorder of sexual differentiation |
| RS11571587 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS115716101 |
IFT172
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 10 with or without polydactyly, Retinitis pigmentosa 71 |
| RS11571640 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS11571655 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS11571658 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS11571659 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS11571660 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS115716690 |
KCNJ11
|
Health Risk |
Likely pathogenic |
Neonatal diabetes mellitus, Neonatal diabetes mellitus |
| RS11571675 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS115717092 |
CFAP61
|
Health Risk |
Pathogenic |
Spermatogenic failure 84, Spermatogenic failure 84 |
| RS1157173095 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS11571747 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1157175258 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS1157177960 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS11571819 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1157198543 |
SLC22A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS11572191 |
CYP2J2
|
Health Risk |
association |
Pulmonary disease, chronic obstructive |
| RS1157219727 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1157238971 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
CEP290-related disorder, Meckel-Gruber syndrome |
| RS1157259307 |
ARSG
|
Health Risk |
Pathogenic |
— |
| RS1157267701 |
QARS1
|
Health Risk |
Pathogenic |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome |
| RS1157280571 |
F12
|
Health Risk |
Pathogenic |
FACTOR XII (WASHINGTON D.C.), FACTOR XII (WASHINGTON D.C.) |
| RS1157281284 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1157287613 |
UNC13D
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis |
| RS1157288312 |
ERCC6
|
Health Risk |
Likely pathogenic |
— |
| RS115729513 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Collagen 6-related myopathy |
| RS1157302392 |
TCTN3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Orofacial-digital syndrome IV |
| RS1157302803 |
CRPPA
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2U, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS115730708 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS1157311218 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1157312147 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 11 |
| RS1157335847 |
NIPBL
|
Health Risk |
Pathogenic/Likely pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1157340043 |
CDH3
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS115735611 |
GIGYF2
|
Health Risk |
risk factor |
Parkinson disease 11, autosomal dominant |
| RS115735993 |
PCLO
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, PCLO-related disorder |
| RS115736276 |
PRKCG
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1157393817 |
LPL
|
Health Risk |
Likely pathogenic |
— |
| RS11574107 |
VDR
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS11574115 |
VDR
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS11574116 |
VDR
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin D-dependent rickets type II with alopecia, VDR-related disorder |
| RS11574117 |
VDR
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS1157413766 |
MRE11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder |
| RS1157417207 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS115742228 |
MYH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Distal arthrogryposis type 2B1, Freeman-Sheldon syndrome |
| RS11574250 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Werner syndrome |
| RS11574323 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Werner syndrome |
| RS1157436927 |
MRE11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder |
| RS11574410 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Wiskott-Aldrich syndrome |
| RS115744476 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |